U.S. External Defibrillators Market Size, Share & Trends Analysis Report By Product (Manual, Automated, Wearable), By End-use (Hospital, Prehospital, Public Access Market), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. External Defibrillators Market Growth & Trends
The U.S. external defibrillators market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of cardiovascular conditions is a major factor contributing to market growth. As per the Centers for Disease Control and Prevention (CDC), every year in the U.S., around 805,000 people have a heart attack. Technological advancements have led to the development of innovative external defibrillators. In addition, the growing healthcare expenditure in the U.S., coupled with investments in emergency medical services and healthcare infrastructure, has supported the product adoption in hospitals, clinics, ambulances, and other healthcare facilities.
This increased investment in healthcare facilities has boosted the demand for advanced defibrillation technologies. Public awareness campaigns about sudden cardiac arrest & the importance of early defibrillation, along with training programs on using automated external defibrillators (AEDs) effectively, have played a crucial role in driving market growth. Increased awareness has led to a higher demand for defibrillators in public settings and private organizations. Key companies undertake various strategies, such as new product launches, M&As, and partnerships, to gain higher market shares. For instance, in March 2023, Safe Life acquired Coro Medical and AED.us. This acquisition helped expand Safe Life’s life-saving equipment and services across the U.S.
U.S. External Defibrillators Market Report Highlights
U.S. External Defibrillators Market Growth & Trends
The U.S. external defibrillators market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of cardiovascular conditions is a major factor contributing to market growth. As per the Centers for Disease Control and Prevention (CDC), every year in the U.S., around 805,000 people have a heart attack. Technological advancements have led to the development of innovative external defibrillators. In addition, the growing healthcare expenditure in the U.S., coupled with investments in emergency medical services and healthcare infrastructure, has supported the product adoption in hospitals, clinics, ambulances, and other healthcare facilities.
This increased investment in healthcare facilities has boosted the demand for advanced defibrillation technologies. Public awareness campaigns about sudden cardiac arrest & the importance of early defibrillation, along with training programs on using automated external defibrillators (AEDs) effectively, have played a crucial role in driving market growth. Increased awareness has led to a higher demand for defibrillators in public settings and private organizations. Key companies undertake various strategies, such as new product launches, M&As, and partnerships, to gain higher market shares. For instance, in March 2023, Safe Life acquired Coro Medical and AED.us. This acquisition helped expand Safe Life’s life-saving equipment and services across the U.S.
U.S. External Defibrillators Market Report Highlights
- The AED product segment dominated the market in 2023 and around for a share of 40% of the overall revenue. The segment is expected to grow at the fastest CAGR from 2024 to 2030
- This can be attributed to the technological advancements in defibrillator devices, increasing prevalence of cardiovascular diseases (CVDs), and growing awareness about the importance of immediate cardiac care
- The hospital end-use segment accounted for the largest revenue share of over 25% in 2023 owing to increased rates of hospital admissions due to heart conditions and increasing defibrillator installations
- The public access end-use segment is anticipated to witness the fastest CAGR from 2024 to 2030 due to the rising awareness of the importance of early defibrillation and training programs
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. EXTERNAL DEFIBRILLATORS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidences of cardiac arrest
3.2.1.2. Technological advancements
3.2.1.3. Increasing healthcare expenditure
3.2.1.4. Growing awareness and training program
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. Limited accessibility
3.3. U.S. External Defibrillators Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. EXTERNAL DEFIBRILLATORS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. External Defibrillators Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
4.4.1. Manual
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Automated
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Wearable Cardioverter Defibrillators
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. EXTERNAL DEFIBRILLATORS MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. External Defibrillators Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Hospital
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Prehospital
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Public Access Market
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Alternate Care Market
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Home Healthcare
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. Koninklijke Philips N.V.
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. ZOLL Medical Corporation
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Stryker
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Nihon Kohden Corporation
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Shenzhen Mindray Bio-Medical Electronics
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Schiller Americas, inc.
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Medtronic
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Amiitalia
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. MEDIANA Co., Ltd.
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. EXTERNAL DEFIBRILLATORS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidences of cardiac arrest
3.2.1.2. Technological advancements
3.2.1.3. Increasing healthcare expenditure
3.2.1.4. Growing awareness and training program
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations & approvals
3.2.2.2. Limited accessibility
3.3. U.S. External Defibrillators Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. EXTERNAL DEFIBRILLATORS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. External Defibrillators Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
4.4.1. Manual
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Automated
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Wearable Cardioverter Defibrillators
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. EXTERNAL DEFIBRILLATORS MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. External Defibrillators Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Hospital
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Prehospital
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Public Access Market
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Alternate Care Market
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Home Healthcare
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company heat map analysis, 2023
6.4. Company Profiles
6.4.1. Koninklijke Philips N.V.
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. ZOLL Medical Corporation
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Stryker
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Nihon Kohden Corporation
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Shenzhen Mindray Bio-Medical Electronics
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Schiller Americas, inc.
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Medtronic
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Amiitalia
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. MEDIANA Co., Ltd.
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. external defibrillators market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. external defibrillators market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 U.S. external defibrillators market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. external defibrillators market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. external defibrillators market: market outlook
Fig. 9 U.S. external defibrillators competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. external defibrillators market driver impact
Fig. 14 U.S. external defibrillators market restraint impact
Fig. 15 U.S. external defibrillators market: Product movement analysis
Fig. 16 U.S. external defibrillators market: Product outlook and key takeaways
Fig. 17 Manual market estimates and forecast, 2018 - 2030
Fig. 18 Automated market estimates and forecast, 2018 - 2030
Fig. 19 Wearable cardioverter defibrillators market estimates and forecast, 2018 - 2030
Fig. 20 U.S. external defibrillators Market: End-use movement Analysis
Fig. 21 U.S. external defibrillators market: End-use outlook and key takeaways
Fig. 22 Hospital market estimates and forecasts, 2018 - 2030
Fig. 23 Pre-hospital market estimates and forecasts, 2018 - 2030
Fig. 24 Public access market estimates and forecasts, 2018 - 2030
Fig. 25 Alternate care market estimates and forecasts, 2018 - 2030
Fig. 26 Home healthcare market estimates and forecasts, 2018 - 2030
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. external defibrillators market: market outlook
Fig. 9 U.S. external defibrillators competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. external defibrillators market driver impact
Fig. 14 U.S. external defibrillators market restraint impact
Fig. 15 U.S. external defibrillators market: Product movement analysis
Fig. 16 U.S. external defibrillators market: Product outlook and key takeaways
Fig. 17 Manual market estimates and forecast, 2018 - 2030
Fig. 18 Automated market estimates and forecast, 2018 - 2030
Fig. 19 Wearable cardioverter defibrillators market estimates and forecast, 2018 - 2030
Fig. 20 U.S. external defibrillators Market: End-use movement Analysis
Fig. 21 U.S. external defibrillators market: End-use outlook and key takeaways
Fig. 22 Hospital market estimates and forecasts, 2018 - 2030
Fig. 23 Pre-hospital market estimates and forecasts, 2018 - 2030
Fig. 24 Public access market estimates and forecasts, 2018 - 2030
Fig. 25 Alternate care market estimates and forecasts, 2018 - 2030
Fig. 26 Home healthcare market estimates and forecasts, 2018 - 2030
